CarsonAllaria Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CarsonAllaria Wealth Management's PFE Position: Q2 2026 in Review
CarsonAllaria Wealth Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $3.74K and bringing the position to 13,244 shares worth $319K. The position accounts for 0.14% of the portfolio, ranked #46.
CarsonAllaria Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $864K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- CarsonAllaria Wealth Management held 13,244 shares of Pfizer worth $319K as of Q2 2026.
- CarsonAllaria Wealth Management bought 143 Pfizer shares in Q2 2026, an estimated $3.74K.
- Pfizer made up 0.14% of CarsonAllaria Wealth Management's portfolio in Q2 2026, its #46 holding.
- CarsonAllaria Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- CarsonAllaria Wealth Management's Pfizer position peaked at $864K in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on CarsonAllaria Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.